That is the first thing ever posted on this board that was accurate. I did enjoy laughing at you when your ignorance made you post that it would be 5 years before MNTA gets another product approved. Did you ever hear of Copaxone? Did you ever hear of MNTA's generic version of Copaxone called M356? I would bet NO.
If MNTA drops enough, I will buy more. I did notice how you avoided commenting on how much better MNTA's cash position is than you stated, on how there won't be a need for a secondary offering for 2-3 years, or how much underwater you are on your short at $10.50. Bwwaaa HHaaa.